Related Experiment Video

Updated: Jul 1, 2026

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats
04:11

A Conditioned Place Preference Protocol for Measuring Incubation of Craving in Rats

Published on: November 6, 2018

Differences between and combinations of opioids re-visited

Maree T Smith1

  • 1Centre for Integrated Preclinical Drug Development and School of Pharmacy, University of Queensland, St Lucia Campus, Brisbane, Queensland, Australia. maree.smith@uq.edu.au

Current Opinion in Anaesthesiology
|September 12, 2008
PubMed
Abstract

Insights

Understanding opioid receptor signaling diversity can lead to new pain relief medications. Research shows different opioids have unique effects, offering hope for better tolerability and pain management.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Pain Management

Background:

  • Opioid analgesics are crucial for pain management but often cause significant side effects.
  • Recent research suggests variability in opioid receptor interactions and signaling pathways.

Purpose of the Study:

  • To review current findings on between-opioid differences in patient outcomes and receptor interactions.
  • To explore the potential for developing novel opioid analgesics with improved tolerability based on signaling diversity.

Main Methods:

  • Review of recent clinical trials and animal study findings.
  • Analysis of opioid receptor signaling mechanisms, including splice variants and heterodimerization.
  • Pharmacological comparison of different strong opioids, such as oxycodone and morphine.

Main Results:

  • Opioid rotation is effective in improving tolerability and analgesia for many patients.
  • Individual opioids may interact with different receptor sub-populations or modulate signaling uniquely.
  • Novel mu opioid splice variants influence native receptor function, indicating signaling diversity.
  • Oxycodone exhibits a distinct in-vivo pharmacological profile compared to morphine.
  • Combined opioid analgesics show promise for effective pain relief with fewer side effects.

Conclusions:

  • Understanding opioid signaling diversity is key to developing safer and more effective opioid analgesics.
  • Exploiting these differences could lead to novel pain management strategies with improved patient tolerability.

More Related Videos

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS10:13

Fentanyl Analog Screening using LC-TIMS-TOF MS/MS

Published on: November 8, 2024

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...